5 reports

  • 5.2 Regional Competitive Landscape
  • 5.1 Global Competitive Landscape

Global Allergy Immunotherapy (AIT) Market (2018-2022 Edition) October 2018 Table of Content ##.

  • Allergy Immunotherapy
  • Immunotherapy
  • World
  • Market Size
  • Allergy Therapeutics plc
  • Mar 16, 2017: Allergy Therapeutics Announces First Patient Recruited in Pivotal Phase III Birch Immunotherapy B301 Study
  • 06/25/2018: Allergy Therapeutics announces publication of data demonstrating longlasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy

One of the key markets for this global product is expected to be the US.

  • Immunotherapy
  • Europe
  • United States
  • Company Financials
  • Allergy Therapeutics plc

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ASIT Biotech SA ## ## ## ## ## ## ## ## Anergis SA ## ## ## ## ## ## ## ## Allied Researc

  • Allergy
  • Clinical Trial
  • Immunotherapy
  • Therapy
  • Allergy Therapeutics plc
  • ALK-ABELLO AS
  • ALLERGOPHARMA GMBH & CO KG

The drug candidate is an immunotherapy.

  • Allergy Drug
  • Eye Disease
  • Immunotherapy
  • Ophthalmic Solution
  • Allergy Therapeutics plc
  • ALK-ABELLO AS
  • RHINO-CONJUNCTIVITIS - PIPELINE BY ALLERGY THERAPEUTICS PLC, H2 2017

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Allergy Drug
  • Eye Disease
  • Immunotherapy
  • Ophthalmic Solution
  • Allergy Therapeutics plc